Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Addiction medication access lags for Black, Hispanic patients
Health and Wellness

Addiction medication access lags for Black, Hispanic patients

Last updated: June 26, 2025 8:52 am
Share
Addiction medication access lags for Black, Hispanic patients
SHARE

Racial Disparities in Opioid Addiction Treatment Persist

A recent study published in JAMA Network Open has shed light on the significant disparities in access to medications for opioid addiction treatment among Black and Hispanic individuals compared to their white counterparts. The study, led by Utsha Khatri, an assistant professor at the Icahn School of Medicine at Mount Sinai, analyzed data from over 176,000 health events related to substance use, revealing that Black and Hispanic patients were 17.1% and 16.2% less likely, respectively, to receive medications like buprenorphine or naltrexone within 180 days of a substance use-related health care event.

The research, which drew data from multiple payers including Medicaid programs, Medicare Advantage, and private commercial insurers, highlighted the stark disparities in the quality of addiction treatment based on race. Notably, patients with government-backed insurance options, such as Medicaid or Medicare Advantage, were more likely to receive opioid addiction medications than those with commercial insurance.

While the study focused on buprenorphine and naltrexone, it did not include data on methadone, the most effective treatment for opioid use disorder. Buprenorphine and naltrexone are often considered lower-barrier options due to their less stringent requirements compared to methadone. Buprenorphine can be easily prescribed by most doctors and picked up at pharmacies, while naltrexone, marketed as Vivitrol, helps curb opioid cravings in individuals who are already abstinent.

Despite advancements in access to opioid addiction medications in recent years, racial disparities persist, reflecting broader systemic issues. Tracie Gardner, a policy advocate and founder of the National Black Harm Reduction Network, highlighted the limited access to health services in communities of color, stigma around medication-assisted treatment for addiction, and the disproportionate incarceration of Black individuals as contributing factors to the disparities.

See also  How 'The Gilded Age' Got Access to Newport's Historic Mansions

To address these disparities, the study’s authors advocate for culturally sensitive care, standardized screening for opioid use disorder, and the integration of addiction care and medication prescribing across the health system. They point to Medicaid programs as a model for providing comprehensive coverage for all approved medications for opioid use disorder and offering coordinated care models.

In light of ongoing discussions to potentially roll back Medicaid benefits, the authors stress the importance of expanding Medicaid to eligible individuals to ensure equitable access to addiction treatment. Despite recent decreases in overdose death rates, Khatri warns that not all communities have benefited equally from policy changes and funding allocations. It is crucial to prioritize marginalized communities that have historically been criminalized for substance use disorder to ensure that progress in addressing the opioid epidemic is inclusive and equitable.

TAGGED:AccessAddictionBlackHispaniclagsMedicationpatients
Share This Article
Twitter Email Copy Link Print
Previous Article Prince Harry ‘Plotting Return To Royal Family’ Prince Harry ‘Plotting Return To Royal Family’
Next Article How To Watch 28 Days Later & 28 Weeks Later For Free In The UK & US How To Watch 28 Days Later & 28 Weeks Later For Free In The UK & US
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

I’m American. My Boyfriend’s Not. Trump’s Immigration Crackdown Could Force Us Apart.

In August of last year, I made the decision to leave my familiar college town…

May 29, 2025

Texas Schools Ban Lesson Over Exposed Nipple on Virginia Flag 

The Lamar Consolidated Independent School District (LCISD) in Texas recently made headlines for removing a…

April 23, 2025

“Got a worn-out bullpen, it’s their own fault”

The Los Angeles Dodgers are currently facing a challenging situation with injuries to several of…

September 25, 2024

The Best Airbnbs in Scotland for a Folkloric Fall Getaway

Every product showcased in Vogue is carefully chosen by our editors. We may, however, earn…

October 12, 2025

Amendment to Duties to Address the Flow of Illicit Drugs Across Our Southern Border – The White House

President Trump Adjusts Tariffs on Mexican Automotive Parts By the authority vested in me as…

March 7, 2025

You Might Also Like

Medicare, midterm elections, Vinay Prasad: Morning Rounds
Health and Wellness

Medicare, midterm elections, Vinay Prasad: Morning Rounds

October 31, 2025
Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests
Health and Wellness

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

October 31, 2025
Once Again A Blood Pressure Medication Recall For Cancer Concerns
Health and Wellness

Once Again A Blood Pressure Medication Recall For Cancer Concerns

October 31, 2025
IVF research, FDA vouchers, dementia: Morning Rounds
Health and Wellness

IVF research, FDA vouchers, dementia: Morning Rounds

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?